Obtaining recognized the palmitoylation motif of APLNR, we designed a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web site in combination with morphine, can inhibit the development of NCP, such as pain incidence, microglial activation, and inflammatory https://seanl628guz4.activosblog.com/26369029/fascination-about-block-pain-receptors-with-proleviate